Activation of the HMGB1-RAGE axis upregulates TH expression in dopaminergic neurons via JNK phosphorylation

Biochem Biophys Res Commun. 2017 Nov 4;493(1):358-364. doi: 10.1016/j.bbrc.2017.09.017. Epub 2017 Sep 5.

Abstract

The derangement of tyrosine hydroxylase (TH) activity reduces dopamine synthesis and is implicated in the pathogenesis of Parkinson's disease. However, the extracellular modulator and intracellular regulatory mechanisms of TH have yet to be identified. Recently, high-mobility group box 1 (HMGB1) was reported to be actively secreted from glial cells and is regarded as a mediator of dopaminergic neuronal loss. However, the mechanism for how HMGB1 affects TH expression, particularly through the receptor for advanced glycation endproducts (RAGE), has not yet been investigated. We found that recombinant HMGB1 (rHMGB1) upregulates TH mRNA expression via simultaneous activation of JNK phosphorylation, and this induction of TH expression is blocked by inhibitors of RAGE and JNK. To investigate how TH expression levels change through the HMGB1-RAGE axis as a result of MPP+ toxicity, we co-treated SN4741 dopaminergic cells with MPP+ and rHMGB1. rHMGB1 blocked the reduction of TH mRNA following MPP+ treatment without altering cell survival rates. Our results suggest that HMGB1 upregulates TH expression to maintain dopaminergic neuronal function via activating RAGE, which is dependent on JNK phosphorylation.

Keywords: Dopaminergic neurons; High-mobility group box 1; JNK; Parkinson's disease; Tyrosine hydroxylase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Dopaminergic Neurons / physiology*
  • HMGB1 Protein / metabolism*
  • MAP Kinase Kinase 4 / metabolism*
  • Phosphorylation
  • Rats
  • Receptor for Advanced Glycation End Products / metabolism*
  • Signal Transduction / physiology*
  • Tyrosine 3-Monooxygenase / metabolism*
  • Up-Regulation / physiology

Substances

  • Ager protein, rat
  • HMGB1 Protein
  • Hbp1 protein, rat
  • Receptor for Advanced Glycation End Products
  • Tyrosine 3-Monooxygenase
  • MAP Kinase Kinase 4